Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 406–420 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1470 Irinotecan Toxicity Assessment (UGT1A1 Genotyping)/Gilbert Syndrome Test This test evaluates genetic variants in the UGT1A1 gene associated with irinotecan toxicity and Gilbert syndrome.	Peripheral Blood (EDTA tube)	7–8 Days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene variants (28, 6, *60)", "Genetic predisposition to irinotecan toxicity", "Genetic confirmation of Gilbert syndrome"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Predicting severe adverse reactions to irinotecan chemotherapy", "Diagnosing Gilbert syndrome", "Personalizing irinotecan dosage"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z13.89, E80.4 Clinical summary This test evaluates genetic variants in the UGT1A1 gene associated with irinotecan toxicity and Gilbert syndrome.
TEST-5323 ITGA7 Gene Myopathy (Integrin Alpha‑7 Deficiency) Genetic Test This genetic test evaluates the ITGA7 gene for pathogenic variants associated with congenital muscular dystrophy due to integrin α7 deficiency.	Peripheral whole blood (3–5 mL EDTA) or Buccal Swab / DNA FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ITGA7 gene", "Presence of single-nucleotide variants and small indels"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected ITGA7-related congenital myopathy", "Family history of early-onset myopathy", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81252-6 ICD-10: G71.2 Clinical summary This genetic test evaluates the ITGA7 gene for pathogenic variants associated with congenital muscular dystrophy due to integrin α7 deficiency.
TEST-6124 ITGB1 Gene Leukocyte Adhesion Deficiency (LAD) Genetic Test This test sequences the ITGB1 gene to identify pathogenic variants associated with Leukocyte Adhesion Deficiency (LAD). It helps confirm the diagnosis in patients presenting with r...	Blood (Whole Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITGB1 gene sequence", "Pathogenic variants in ITGB1"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Documented family pedigree required", "Provide detailed clinical history to the ordering physician"] Indications ["Suspected Leukocyte Adhesion Deficiency (LAD)", "Recurrent severe infections", "Family history of primary immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D84.8, D72.0 Clinical summary This test sequences the ITGB1 gene to identify pathogenic variants associated with Leukocyte Adhesion Deficiency (LAD). It helps confirm the diagnosis in patients presenting with recurrent infections, impaired wound healing, and leukocytosis.
TEST-3163 ITGB3 Gene Neonatal Alloimmune Thrombocytopenia Genetic Test This diagnostic test evaluates the ITGB3 gene for variants associated with Neonatal Alloimmune Thrombocytopenia (NAIT). It identifies mutations that can lead to low platelet counts...	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITGB3 gene variants", "Pathogenic mutations associated with NAIT"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications without consulting your physician."] Indications ["Prenatal risk assessment for NAIT", "Post-natal management of affected newborns", "Families with a history of neonatal thrombocytopenia"] Measurement technique Confirm with laboratory Codes LOINC: 82857-5 ICD-10: D69.51 Clinical summary This diagnostic test evaluates the ITGB3 gene for variants associated with Neonatal Alloimmune Thrombocytopenia (NAIT). It identifies mutations that can lead to low platelet counts in newborns.
TEST-6249 ITIH4 Gene Hypercholesterolemia Susceptibility Genetic Test This genetic test evaluates specific DNA variants within the ITIH4 gene associated with an increased risk of developing hypercholesterolemia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNA variants in the ITIH4 gene", "Genetic susceptibility to hypercholesterolemia"] Parameters [] Preparation ["No fasting required", "Attend pre-test genetic counselling session", "Complete pedigree chart and provide clinical history"] Indications ["Early cardiovascular risk stratification", "Family cascade screening for hypercholesterolemia", "Personalized prevention strategies based on genetic risk"] Measurement technique Confirm with laboratory Codes LOINC: 51963-7 ICD-10: E78.0 Clinical summary This genetic test evaluates specific DNA variants within the ITIH4 gene associated with an increased risk of developing hypercholesterolemia.
TEST-2296 JAK2 Exon 12 Mutation Detection Test This test detects mutations in the JAK2 gene's exon 12 region, aiding in the diagnosis of specific myeloproliferative neoplasms like polycythemia vera.	Peripheral Whole Blood (EDTA Lavender-Top Tube)	3–4 days (Sample Mon/Thu by 11 am; Report Wed/Sat)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 Exon 12 insertions", "JAK2 Exon 12 deletions", "JAK2 Exon 12 point mutations"] Parameters [] Preparation ["No special preparation needed"] Indications ["Diagnosis of polycythemia vera in V617F-negative patients", "Workup for other myeloproliferative neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 92735-6 ICD-10: D45 Clinical summary This test detects mutations in the JAK2 gene's exon 12 region, aiding in the diagnosis of specific myeloproliferative neoplasms like polycythemia vera.
TEST-3126 JAK2 Gene Familial Thrombocytosis NGS Test This test evaluates the JAK2 gene for mutations associated with familial thrombocytosis and myeloproliferative neoplasms using Next-Generation Sequencing.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene mutations (V617F, exon 12, rare variants)", "Presence of inherited or acquired mutations"] Parameters [] Preparation ["No specific fasting required", "Do not stop or adjust prescribed medication before the test without consulting your treating physician"] Indications ["Individuals with persistent unexplained thrombocytosis", "Family history of myeloproliferative neoplasms", "Suspicion of JAK2 mutation-associated disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92819-1 ICD-10: D47.3, Z82.1 Clinical summary This test evaluates the JAK2 gene for mutations associated with familial thrombocytosis and myeloproliferative neoplasms using Next-Generation Sequencing.
TEST-1900 JAK2 Gene Mutation Analysis (Essential Thrombocythemia Type 3) Test This test detects somatic mutations in the JAK2 gene, including the common V617F variant and rare mutations, using Next-Generation Sequencing.	Peripheral Whole Blood	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene somatic mutations", "V617F variant", "Rare JAK2 variants"] Parameters [] Preparation [] Indications ["Diagnosis of essential thrombocythemia", "Risk stratification in myeloproliferative neoplasms", "Therapeutic monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 33453-8 ICD-10: D47.3 Clinical summary This test detects somatic mutations in the JAK2 gene, including the common V617F variant and rare mutations, using Next-Generation Sequencing.
TEST-2027 JAK2 Gene Mutation NGS Test for Acute Myelogenous Leukemia (AML) This test evaluates the presence of mutations within the coding regions and splice sites of the JAK2 gene.	Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene mutations", "Variant Allele Frequency (VAF)"] Parameters [] Preparation ["Genetic counseling session recommended", "No fasting required", "Avoid eating, drinking, or smoking for 30 minutes before buccal swab collection"] Indications ["AML subtype confirmation", "JAK inhibitor eligibility assessment", "Prognosis stratification"] Measurement technique Confirm with laboratory Codes LOINC: 92806-5 ICD-10: C92.00 Clinical summary This test evaluates the presence of mutations within the coding regions and splice sites of the JAK2 gene.
TEST-2038 JAK2 Mutation Analysis (Exons 12, 14, 16) by Next-Generation Sequencing (NGS) Test This test identifies specific mutations in the JAK2 gene (exons 12, 14, 16) associated with myeloproliferative neoplasms.	Whole blood (EDTA), buccal swab, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene mutations", "Somatic mutations in exons 12, 14, 16"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Diagnosis of Philadelphia-negative myeloproliferative neoplasms (MPNs)", "Risk stratification for thrombotic events", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 82939-2 ICD-10: D45, D47.3, D47.1 Clinical summary This test identifies specific mutations in the JAK2 gene (exons 12, 14, 16) associated with myeloproliferative neoplasms.
TEST-777 JAK2 Mutation Detection (RNA) Qualitative Test This test detects the presence or absence of the JAK2 V617F mutation in RNA extracted from peripheral whole blood.	Peripheral whole blood	24 h (phone) / 36 h (email) – 3rd working day report	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation (c.1849G>T) in RNA transcript"] Parameters [] Preparation ["No special preparation needed", "May eat and drink normally", "Continue prescribed medications"] Indications ["Diagnosis of Philadelphia-negative MPNs (polycythemia vera, essential thrombocythemia, primary myelofibrosis)", "Differentiation of primary vs. secondary MPNs", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 36882-3 ICD-10: D47.1 Clinical summary This test detects the presence or absence of the JAK2 V617F mutation in RNA extracted from peripheral whole blood.
TEST-1462 JAK2 Mutation Detection Panel (Exon 12) Test This test detects rare pathogenic variants in the JAK2 gene, specifically within exon 12, using Sanger sequencing.	Peripheral Blood or Bone Marrow Aspirate	7–8 business days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene exon 12 variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Inform provider if on anticoagulant therapy", "Doctor's prescription is mandatory"] Indications ["Diagnosis of polycythemia vera", "Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Negative JAK2 V617F mutation test"] Measurement technique Confirm with laboratory Codes LOINC: 78299-7 ICD-10: D45 Clinical summary This test detects rare pathogenic variants in the JAK2 gene, specifically within exon 12, using Sanger sequencing.
TEST-1467 JAK2 Mutation Detection Panel (Exons 12-15) Test This diagnostic test evaluates for mutations within exons 12-15 of the JAK2 gene, which are associated with specific types of myeloproliferative neoplasms.	Peripheral whole blood (preferred); bone marrow aspirate (hospital extraction only)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene mutations (exons 12-15)", "Presence of specific variants like K539L, N542‑E543del, F537‑I546dup"] Parameters [] Preparation ["No special preparation required for peripheral blood collection", "Fasting for at least 6 hours if bone marrow aspiration is needed"] Indications ["Diagnosis of suspected Philadelphia-negative myeloproliferative neoplasms (MPNs)", "Differentiation between polycythemia vera, essential thrombocythemia, and primary myelofibrosis", "Evaluation when JAK2 V617F test is negative"] Measurement technique Confirm with laboratory Codes LOINC: 33953-9 ICD-10: D47.1, D45, D47.3, D47.4 Clinical summary This diagnostic test evaluates for mutations within exons 12-15 of the JAK2 gene, which are associated with specific types of myeloproliferative neoplasms.
TEST-2331 JAK2 Mutation Detection, Qualitative PCR Test This test detects the presence or absence of the JAK2 V617F mutation in a blood sample.	Whole blood (EDTA)	Sample Mon/Thu by 11 am; Report Wed/Sat	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation"] Parameters [] Preparation ["No fasting required", "Ensure Genomics Clinical Information Requisition Form (Form 20) is completed"] Indications ["Suspected polycythemia vera", "Suspected essential thrombocythemia", "Suspected primary myelofibrosis"] Measurement technique Confirm with laboratory Codes LOINC: 33717-0 ICD-10: D47.1 Clinical summary This test detects the presence or absence of the JAK2 V617F mutation in a blood sample.
TEST-1458 JAK2 V617F Quantitative Mutation Analysis Test This test quantifies the percentage of JAK2 V617F mutation allele burden in a patient's blood.	Peripheral whole blood	3–4 working days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation allele burden"] Parameters [{"name": "Mutant Allele Burden", "reference_range": "0.1% – 100% allele burden (linear dynamic range)"}, {"name": "Limit of Detection", "reference_range": "1% mutant allele"}] Preparation ["No fasting or special preparation is required."] Indications ["Diagnosis of polycythemia vera (PV)", "Diagnosis of essential thrombocythemia (ET)", "Diagnosis of primary myelofibrosis (PMF)", "Monitoring minimal residual disease during treatment"] Measurement technique Confirm with laboratory Codes LOINC: 91062-1 ICD-10: D45, D75.A, D47.4 Clinical summary This test quantifies the percentage of JAK2 V617F mutation allele burden in a patient's blood.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories